For example, a study implementing mouse tumor-associated endothelial cells (TECs) demonstrated how FGF can promote a differential cell response by reducing TGF-β-induced contractile and myofibroblastic properties, while concurrently promoting cell proliferation and motility [75]. The gene discussed is TGFB1; the disease is neoplasm.